(Q42598501)

3 November 2017

DUROS technology delivers peptides and proteins at consistent rate continuously for 3 to 12 months (English)

1 reference

3 November 2017

Catherine M Rohloff

1

1 reference

3 November 2017

Thomas R Alessi

2

1 reference

3 November 2017

Bing Yang

3

1 reference

3 November 2017

Janice Dahms

4

1 reference

3 November 2017

John P Carr

5

1 reference

3 November 2017

Scott D Lautenbach

6

1 reference

3 November 2017

1 May 2008

1 reference

Journal of Diabetes Science and Technology

3 November 2017

1 reference

3 November 2017

2

1 reference

3 November 2017

3

1 reference

3 November 2017

461-467

1 reference

The Physiology of Glucagon-like Peptide 1

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2769721

Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2769721

Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2769721

Patient-reported experience with the Viadur 12-month leuprolide implant for prostate cancer

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2769721

An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2769721

Safety and efficacy of an implantable leuprolide delivery system in patients with advanced prostate cancer.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2769721

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2769721

Characterization and comparison of leuprolide degradation profiles in water and dimethyl sulfoxide

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19885211

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/193229680800200316

1 reference

3 November 2017

1 reference

3 November 2017

1 reference